EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C18H16ClFN2O2 |
| Net Charge | 0 |
| Average Mass | 346.789 |
| Monoisotopic Mass | 346.08843 |
| SMILES | CCC(=O)N1CC(=O)Nc2ccc(Cl)cc2C1c1ccc(F)cc1 |
| InChI | InChI=1S/C18H16ClFN2O2/c1-2-17(24)22-10-16(23)21-15-8-5-12(19)9-14(15)18(22)11-3-6-13(20)7-4-11/h3-9,18H,2,10H2,1H3,(H,21,23) |
| InChIKey | UOYNCKOPUNYWCU-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 7-chloro-5-(4-fluorophenyl)-4-(1-oxopropyl)-3,5-dihydro-1H-1,4-benzodiazepin-2-one (CHEBI:116991) is a benzodiazepine (CHEBI:22720) |
| Manual Xrefs | Databases |
|---|---|
| LSM-28439 | LINCS |